Core Viewpoint - Tevogen Bio Holdings Inc. is launching Tevogen Generics to address the increasing national focus on pharmaceutical affordability, coinciding with recent tariff-related statements from President Donald Trump [1][2]. Group 1: Company Initiatives - Tevogen Generics is established as the third strategic pillar of Tevogen Bio Holdings Inc., alongside Tevogen Bio and Tevogen.AI [3][7]. - The initiative aims to expedite domestic manufacturing of unbranded pharmaceuticals and active pharmaceutical ingredients (APIs), enhancing national self-reliance in vital treatments [2]. Group 2: Leadership and Management - Sadiq Khan, the Chief Commercial Officer, has been appointed as the Interim Head of Tevogen Generics, bringing decades of experience in global commercial operations [2].
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump's Initiative to Encourage Pharmaceutical Manufacturing in United States